Here are what the editors at HealthDay consider to be the most important developments in Dermatology for September 2010. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Simple Psoriasis Pruritus Self-Assessment Tool Validated
THURSDAY, Sept. 30 (HealthDay News) -- A simple six-point Likert scale is a valid and reliable tool for self-assessment of pruritus by patients with moderate to severe plaque psoriasis, according to research published in the October issue of the Journal of the American Academy of Dermatology.
Molecular Changes Studied for Fractional CO2 Laser Therapy
THURSDAY, Sept. 23 (HealthDay News) -- Fractional carbon dioxide (CO2) laser skin resurfacing results in the same post-treatment molecular changes as fully ablative CO2 laser treatments, according to a study in the September/October issue of the Archives of Facial Plastic Surgery.
Depth of Melanoma Excision Varies by Physician Type
WEDNESDAY, Sept. 22 (HealthDay News) -- The depth of excision of invasive melanomas differs substantially among different types of physicians, according to a study in the September issue of the Archives of Dermatology.
Sunless Tanning Promotion Tied to Reduced Sunbathing
TUESDAY, Sept. 21 (HealthDay News) -- An intervention aimed at promoting the use of sunless tanning products appears to reduce sunbathing and increase sunless tanning, according to a study published in the September issue of the Archives of Dermatology. According to another study in the same issue, approximately 11 percent of U.S. adolescents use sunless tanning products, a practice linked to risky behaviors associated with ultraviolet radiation exposure.
Depression, Burnout Have Dire Impact on Medical Training
TUESDAY, Sept. 14 (HealthDay News) -- Depressed medical students are more likely to endorse depression stigma attitudes than nondepressed students, and those with burnout are more likely to engage in unprofessional conduct and less likely to hold altruistic views of physicians' social responsibilities than those without burnout, according to two articles published in the Sept. 15 issue of the Journal of the American Medical Association.
Sacrifice Makes Industry Gifts Seem More Acceptable
TUESDAY, Sept. 14 (HealthDay News) -- Residents who are reminded of the sacrifices they made to attain their medical education tend to rate the acceptability of industry-sponsored gifts higher than those who are not reminded, according to research published in the Sept. 15 issue of the Journal of the American Medical Association.
Cryotherapy Most Effective Treatment for Common Warts
TUESDAY, Sept. 14 (HealthDay News) -- To cure common warts, cryotherapy is more effective than topical salicylic acid, but for plantar warts, neither treatment is significantly more effective than simply taking a wait-and-see approach, according to a study published online Sept. 13 in CMAJ, the journal of the Canadian Medical Association.
Re-Consent Important Before Secondary Use of Genetic Data
MONDAY, Sept. 13 (HealthDay News) -- Most research participants want to be asked for secondary consent -- referred to as re-consent -- before their existing personal genetic data are added to the federal database of Genotypes and Phenotypes (dbGaP), according to research published in the September issue of the Journal of Empirical Research on Human Research Ethics.
Melanoma Sentinel Node Score Stratifies Risk
THURSDAY, Sept. 9 (HealthDay News) -- A weighted score of non-sentinel node (NSN) indices could predict which patients with sentinel node (SN)-positive melanoma could possibly be spared completion lymph node dissection (CLND), according to research published online Sept. 7 in the Journal of Clinical Oncology.
Annual Medical Liability Costs Surpass $50 Billion
THURSDAY, Sept. 9 (HealthDay News) -- The annual costs of the medical liability system in the United States total more than $50 billion, which accounts for a relatively small but non-trivial portion of total health care spending, according to an article in the September issue of Health Affairs.
Triple Topical Therapy Verified as Gold Standard for Melasma
FRIDAY, Sept. 3 (HealthDay News) -- Compared with triple topical therapy (TTT), non-ablative 1,550 nm fractional laser therapy (FLT) for the treatment of melasma is associated with an increased risk of post-inflammatory hyperpigmentation and lower patient satisfaction scores, according to a study published in the September issue of Lasers in Surgery and Medicine.
Copyright © 2010 ScoutNews, LLC. All rights reserved.
|Previous: September 2010 Briefing - Cardiology||Next: September 2010 Briefing - Diabetes & Endocrinology|
Reader comments on this article are listed below. Review our comments policy.